Zobrazeno 1 - 10
of 32
pro vyhledávání: '"hypoxia conditioned"'
Autor:
Dwight D. Harris, MD, Sharif A. Sabe, MD, Mark Broadwin, MD, Christopher Stone, MD, Cynthia Xu, MD, Meghamsh Kanuparthy, MD, Akshay Malhotra, M. Ruhul Abid, MD, PhD, Frank W. Sellke, MD, FACS
Publikováno v:
JTCVS Open, Vol 20, Iss , Pp 49-63 (2024)
Objective: Coronary artery disease remains a leading cause of morbidity and mortality worldwide. Patients with advanced coronary artery disease who are not eligible for endovascular or surgical revascularization have limited options. Extracellular ve
Externí odkaz:
https://doaj.org/article/5f4afdcb756649dca1e6ceb06d9b4d02
Autor:
Dwight D. Harris, MD, Sharif A. Sabe, MD, Mohamed Sabra, MD, Cynthia M. Xu, MD, Akshay Malhotra, Mark Broadwin, MD, Debolina Banerjee, MD, M. Ruhul Abid, MD, PhD, Frank W. Sellke, MD
Publikováno v:
JTCVS Open, Vol 15, Iss , Pp 220-228 (2023)
Objective: Limited treatments exist for nonoperative chronic coronary artery disease. Previously, our laboratory has investigated extracellular vesicle (EV) therapy as a potential treatment for chronic coronary artery disease using a swine model and
Externí odkaz:
https://doaj.org/article/38099fd14f5e4cf1bade6d4d8db6a084
Autor:
Dwight D. Harris, Sharif A. Sabe, Mark Broadwin, Cynthia Xu, Christopher Stone, Meghamsh Kanuparthy, Akshay Malhotra, M. Ruhul Abid, Frank W. Sellke
Publikováno v:
Bioengineering, Vol 11, Iss 2, p 125 (2024)
Introduction: Patients with advanced coronary artery disease (CAD) who are not eligible for stenting or surgical bypass procedures have limited treatment options. Extracellular vesicles (EVs) have emerged as a potential therapeutic target for the tre
Externí odkaz:
https://doaj.org/article/0145e267b4514c1f8be0ec6b692e164e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Erma Safitri, Mas'ud Hariadi
Publikováno v:
Veterinary World, Vol 12, Iss 6, Pp 916-924 (2019)
Aim: Biotechnological culture of hypoxia-conditioned (CH) rat mesenchymal stem cells (rMSC-CH) for testicular failure therapy with low libido improves the functional outcome of the testicle for producing spermatogenic cells and repairs Leydig cells i
Externí odkaz:
https://doaj.org/article/6c1fe39d19a84f2fbd4cc666b5b935ee
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Erma Safitri, Mas’ud Hariadi
Publikováno v:
Veterinary World
Veterinary World, Vol 12, Iss 6, Pp 916-924 (2019)
Veterinary World, Vol 12, Iss 6, Pp 916-924 (2019)
Aim: Biotechnological culture of hypoxia-conditioned (CH) rat mesenchymal stem cells (rMSC-CH) for testicular failure therapy with low libido improves the functional outcome of the testicle for producing spermatogenic cells and repairs Leydig cells i
Autor:
Anja Lode, Henriette Bretschneider, Stefan Rammelt, Michael Gelinsky, Mandy Quade, Corina Vater
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 11
International Journal of Molecular Sciences, Vol 22, Iss 5836, p 5836 (2021)
Volume 22
Issue 11
International Journal of Molecular Sciences, Vol 22, Iss 5836, p 5836 (2021)
To develop cost-effective and efficient bone substitutes for improved regeneration of bone defects, heparin-modified mineralized collagen scaffolds were functionalized with concentrated, naturally occurring bioactive factor mixtures derived from adip
Autor:
Henriette Bretschneider, Mandy Quade, Anja Lode, Michael Gelinsky, Stefan Rammelt, Stefan Zwingenberger, Klaus-Dieter Schaser, Corina Vater
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 4
International Journal of Molecular Sciences, Vol 21, Iss 4, p 1412 (2020)
Volume 21
Issue 4
International Journal of Molecular Sciences, Vol 21, Iss 4, p 1412 (2020)
In this study, the bone-regenerative potential of bioactive factors derived from adipose tissue, platelet-rich plasma (PRP) and conditioned medium from hypoxia-treated human telomerase immortalized bone-marrow-derived mesenchymal stem cells (hTERT-MS